Eli Lilly To Buy Cancer Treatment Company Loxo Oncology For $8 Billion In Cash
Eli Lilly and Company and Loxo Oncology, Inc. announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion.
